Jpmorgan Chase & CO Matinas Bio Pharma Holdings, Inc. Call Options Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding MTNB
# of Institutions
32Shares Held
36.9MCall Options Held
0Put Options Held
0-
Highbridge Capital Management LLC New York, NY10.6MShares$6.07 Million0.37% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.32MShares$5.31 Million0.0% of portfolio
-
Sargent Investment Group, LLC3.49MShares$1.99 Million0.12% of portfolio
-
Black Rock Inc. New York, NY2.48MShares$1.41 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.29MShares$1.31 Million0.0% of portfolio
About Matinas BioPharma Holdings, Inc.
- Ticker MTNB
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 216,864,992
- Market Cap $124M
- Description
- Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...